Selegiline monotherapy in the treatment of Parkinson's disease.
Koller
W C
WC
Department of Neurology, University of Kansas Medical Center, Kansas City 66160-7314, USA.
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D012642:Selegiline / Q000627:therapeutic use*
D000978:Antiparkinson Agents; D012642:Selegiline